Followers | 88 |
Posts | 8196 |
Boards Moderated | 0 |
Alias Born | 06/17/2013 |
Wednesday, September 06, 2017 10:53:53 AM
http://www.smobserved.com/story/2017/09/05/business/one-giant-leap-forward-in-cancer-treatment-by-therapeutic-solutions-international/3076.html
One Giant Leap Forward in Cancer Treatment by Therapeutic Solutions International
Meet the Next Big Thing in Human Health!
September 5, 2017
Always in our modern history the human world has continued to pursue anything and everything that helps us live longer and better. Way back in 1870 Louis Pasteur established the germ theory of disease widening the door to both treatment and prevention. Twenty years later Emil von Behring discovers antitoxins used to develop tetanus and diphtheria vaccines. By 1952 Jonas Salk revolutionized the world by developing an effective polio vaccine. Then in 1998 James Thompson developed stem cell therapy creating yet another major step forward in beating disease. Now there is something coming together that could easily be a giant leap forward in effectively treating a deadly disease, cancer.
Just a few weeks ago I had the distinct privilege of attending a meeting at the prestigious John
Wayne Cancer Institute in Santa Monica, California. The meeting had been arranged by Therapeutic Solutions International, Inc. an extremely exciting and very unique emerging public company in the health care field. [TSOI:OTC] Therapeutic Solutions International, Inc. is comprised of four diverse human health care companies each with its own vision and track. Each one of these related companies, Emvolio, Inc., OmniBiome, Inc., Sandbox Dental Labs, Inc. and its Nutraceutical Division are bringing amazing and powerful advancements in the realm of human health. Anyone of these entities could on its own make Therapeutic Solutions International, Inc. a huge commercial success but when taken together the potential for this company is nothing short of staggering.
Yet I must confess a bias with a total engagement in the work of Emvolio, Inc. No entity is better than its leadership and the leadership of Emvolio, Inc. is proven, strong, powerful and extremely effective. Dr. Thomas E. Ichim is Chief Executive Officer, Gerry B. Berg is Chief Financial Officer and Director, Timothy G. Dixon is President and Chairman and the Scientific Advisory Board is led by Santosh Kesari, MD, PhD. This company is developing products that can be used together to attack cancer at different levels as well as to be used either alone or in conjunction with existing therapies. They currently have patented products that have so far shown astonishing effectiveness. But yes further clinical trials are necessary to establish efficacy to the levels required by the FDA but they are on their way. As a cancer survivor myself what I heard and saw at this meeting was nothing short of pure beauty. I am not at liberty to discuss in this forum every detail but I can and will make these two suggestions with absolute total conviction.
Do go to their website http://therapeuticsolutionsint.com/ and explore it fully. Then I would unequivocally recommend that you very seriously consider investing in this company which today is trading right around a penny, I see the upside potential here as nothing less than staggering. No guarantees ever, of course, but with my personal experience ranging over more than 50 years I will say without exception I have never seen anything with a stronger upside potential. Better health and a real strong potential for greater wealth, now that is what I call a real win win situation.
Anyone wishing to comment about his article may do so by simply sending me an email to: helloronirwin@gmail.com. If you have any questions about Therapeutic Solutions International, Inc. I will certainly forward them on your behalf.
Recent TSOI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 08:44:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 08:44:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 06:14:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 07:42:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 07:38:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:44:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:39:55 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/31/2024 08:51:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 04:47:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 12:46:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 12:44:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/30/2024 06:46:26 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 04:01:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 10:03:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 07:15:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 07:12:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 10:25:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 11:16:15 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/08/2024 05:15:25 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/06/2024 11:34:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 08:42:55 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/17/2024 11:15:01 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/04/2024 09:03:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 07:44:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:39:49 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM